David Krause April 24, 2025 Technological Innovation The Promise - And Perils - of AI in Fertility David Krause April 24, 2025 Technological Innovation Minimizing Hallucinations & Maximizing Value with AI Tools
David Krause April 24, 2025 Generic Fertility Medications Gain Traction, FSH Biosimilar in Pipeline David Krause April 24, 2025 Pending Policy Changes and Market Shifts Open Doors for Cost-Effective Alternatives
David Krause April 24, 2025 CDC Fires Six Person ARTS Team, Uncertainty on Future of Published Data David Krause April 24, 2025 Sector insiders fear a return to the early days of IVF, when clinics made vastly inflated claims of success.
David Krause April 24, 2025 The Rural Access Crisis: Millions Shut Out of Fertility Care David Krause April 24, 2025 IVF Labs Exist in only 8% of US Counties
Griffin Jones April 17, 2025 Work with the Wind Griffin Jones April 17, 2025 How Inea Collazo Sees the Future of Embryology Work
David Krause April 17, 2025 How fertility providers and medicine suppliers are prepping for potentially expanded IVF access under the new administration David Krause April 17, 2025 How new presidential executive orders might change the fertility field.
David Krause April 10, 2025 Profits Without Purpose David Krause April 10, 2025 Opinion. How the Fertility Industry Failed Its Greatest Advocate
David Krause April 10, 2025 RCM Pressure Mounting. Billing Chaos Drains Clinics and Patients David Krause April 10, 2025 Broken Insurance Processes, Rising Costs, and the Fight for Financial Survival in Fertility Care
David Krause April 10, 2025 Top IVF Experts Convene at Inception’s 2025 Physician Summit David Krause April 10, 2025 Legal insights, network expansion, and cutting-edge genetic testing drive conversations at the annual gathering.
David Krause April 10, 2025 43,000 More Embryologists, 4,000 New IVF Labs Required by 2035 David Krause April 10, 2025 IVF Sector Losing $450B, 95% of Patients Globally with Current Bottleneck
David Krause March 20, 2025 Six Brand New REIs Explain How Their Practices Won Them Over David Krause March 20, 2025 Strug, Kalakota, Szczupak, Kuyoro, Dunn and Rivas weigh in on workplace culture, autonomy, long-term stability
David Krause March 20, 2025 Navigating the Data Overflow: Fertility Clinics Find Relief in AI Platforms David Krause March 20, 2025 97% of IVF Clinic Data Unstructured, Underutilized
David Krause March 20, 2025 Fertility Doctor Participates In $14M Gaia Investment David Krause March 20, 2025 Practice Partner Joins VC Round. Cites Physician Control, Patient Experience
David Krause March 20, 2025 Clinicians Struggle with 3D Uterine Imaging—AI Steps In to Simplify the Process David Krause March 20, 2025 Automation Addresses Workflow Inefficiencies
David Krause March 20, 2025 One Month After Executive Order on IVF, Sector Executives Still Wait For Specifics David Krause March 20, 2025 The Feb. 18 order was intended to expand access to IVF and make it more affordable. But no one really knows what that will entail.
David Krause March 13, 2025 Tracking the REI Fellowship Class of 2024: Where They Went To Work David Krause March 13, 2025 All 60 New REI Specialists and the 56 Practices That Hired Them
David Krause February 20, 2025 Venture Capital Kindbody Tries to Raise $75M As It Shutters Clinics, Shuffles C-Suite David Krause February 20, 2025 Venture Capital The multi-vertical fertility company has been unable to raise significant funding since 2023.
David Krause February 20, 2025 Technological Innovation “We stole from the best.” David Krause February 20, 2025 Technological Innovation Why Conceivable’s AI-Powered Automation of the IVF Lab Succeeds Where Others Have Failed
David Krause February 20, 2025 Pay-Per-Cycle IVF Pricing Is Dead. Outcome Based Pricing Killed It. David Krause February 20, 2025 Clinics turn away from traditional lenders to align with better patient experience
David Krause February 20, 2025 Patient Relations ~50% of Patients Discontinue IVF after failed IVF cycle David Krause February 20, 2025 Patient Relations Factor identified as to whether patients will persist, continue treatment
